It is possible to prevent further nerve damage by controlling your blood sugar. Unfortunately, it won’t reverse the damage or relieve the pain caused by diabetic nerve damage. It may be necessary to receive a specific diabetic nerve pain treatment.
Oral drugs, which just mask the symptoms, are the most commonly used strategy.
- Opioids are used to treat 50 percent of diabetic peripheral neuropathy patients
- Anti-inflammatory medicines are used by 40% of people.
- Serotonin reuptake inhibitors are used by 20% of patients (SSRI)
- Tricyclic inhibitors are used by 11% of people.
- Anticonvulsants are used by 11% of people (Neurontin and Lyrica)
Although a variety of pharmacological medications are available to treat the pain associated with diabetic neuropathy. The US Food and Drug Administration (US FDA) has only approved duloxetine and pregabalin for the treatment of diabetic neuropathic pain.
Pregabalin (Lyrica, Pfizer), the “gold standard” in treating peripheral neuropathy, helps 39 percent of patients attain a 50 percent reduction in their discomfort and pain, but it also causes problems in at least 38 percent of patients. These drugs have significant downsides and side effects. The FDA has not approved over-the-counter pain relievers to treat this type of discomfort.
Combined Therapy
Specialists at Padda Institute use combined therapy to successfully treat diabetic neuropathy. The therapy combines two well-known techniques into a program. It is showing significant promise as a treatment for diabetic and idiopathic neuropathies. Combination therapy consists of two procedures, a local anesthetic Ankle Block and Electronic Signal Therapy (EST), which utilizes a highly sophisticated electro anesthetic wave generator.
Ankle Block
Five nerves important for sensory supply distal to the ankle are targeted by the ankle block. Four branches of the sciatic nerve (superficial peroneal, deep peroneal, sural, and posterior tibial nerve) and a cutaneous branch of the femoral nerve (the saphenous nerve) comprise the nerves. The common peroneal and tibial nerves are two terminal branches of the sciatic nerve.
Electronic Signal Treatment
EST uses electrical signals to regenerate nerves and increase blood flow by stimulating nerve function in the damaged areas. Electronic signal treatment relies on both varied amplitude (AM) and frequency (FM) of electronic signals using computer-controlled, exogenously delivered specific parameters of cell signals.
When applied to the human body, this digitally created electronic sinusoidal alternating current with associated harmonics creates scientifically documented and/or theorized physiological consequences. The electronic signal treatment medical device employs sophisticated communications technology to generate and transfer higher frequency signal energy via customized electrodes in a constantly altering sequential and random manner. This switching between sequential and random electronic signal supply removes neuron accommodation.
With the use of 0.25 percent Marcaine, a local anesthetic, and a vasodilator (opens blood vessels for a short time to enhance blood flow). When your nerves are stimulated, they receive more blood flow, which results in faster regeneration.
Combined therapy is believed to:
- Increases cellular growth
- Increases Metabolic Activity
- Reduces swelling around the nerve
- Stimulates nerve function
- Directly increases blood and oxygen to the nerves
- Promotes wound healing
- Anti-inflammatory action
- Reduces scar tissue development
With a successful and acceptable pain management treatment plan, the patient will be able to regain more mobility.
Auricular vagal nerve stimulation. Where medication and metabolic management have not brought the pain under control, we use the NS-100 — an FDA-cleared Class II programmable peripheral electrical nerve stimulator made by Nalu. It is applied to the auricular branches at the ear and acts as a vagal stimulator, working through how pain signals are processed centrally rather than by interrupting the nerves in the feet. It is worn for up to 30 days, most often around 20. Placement uses local anesthetic with no sedation, you drive yourself home, and there are no activity restrictions. Peripheral nerve stimulation is a covered category under Medicare’s national coverage determination for electrical nerve stimulators, with criteria set by local coverage policy — your own coverage is verified before scheduling. Read more about peripheral nerve stimulation.
Diabetic neuropathy raises the risk of a fall, but it is not the only reason a diabetic patient becomes unsteady — inner-ear function is affected independently of the nerves in the feet. Balance and fall-risk testing measures both.